William T Williams
Overview
Explore the profile of William T Williams including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
763
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Williams W, Lindley K, Liao H, Kamen L, Miller M, Hays A, et al.
Bioanalysis
. 2024 Dec;
17(1):7-15.
PMID: 39696894
Aims: Polyethylene glycol (PEG) is used in many applications including drug development. Due to exposure to environmental products, there is a high prevalence of preexisting anti-PEG antibodies in the global...
2.
Jani D, Marsden R, Gunsior M, Hay L, Ward B, Cowan K, et al.
AAPS J
. 2022 Oct;
24(6):113.
PMID: 36307592
A clear scientific and operational need exists for harmonized bioanalytical immunogenicity study reporting to facilitate communication of immunogenicity findings and expedient review by industry and health authorities. To address these...
3.
Gil G, Smith B, Guerra J, Williams W
Am J Ther
. 2018 Jan;
25(6):e717-e718.
PMID: 29373325
No abstract available.
4.
Shen X, Bogers W, Yates N, Ferrari G, Dey A, Williams W, et al.
J Virol
. 2017 May;
91(19).
PMID: 28490585
Evaluation of the epitope specificities, locations (systemic or mucosal), and effector functions of antibodies elicited by novel HIV-1 immunogens engineered to improve exposure of specific epitopes is critical for HIV-1...
5.
Yates N, Liao H, Fong Y, deCamp A, Vandergrift N, Williams W, et al.
Sci Transl Med
. 2014 Mar;
6(228):228ra39.
PMID: 24648342
HIV-1-specific immunoglobulin G (IgG) subclass antibodies bind to distinct cellular Fc receptors. Antibodies of the same epitope specificity but of a different subclass therefore can have different antibody effector functions....
6.
Zolla-Pazner S, deCamp A, B Gilbert P, Williams C, Yates N, Williams W, et al.
PLoS One
. 2014 Feb;
9(2):e87572.
PMID: 24504509
Unlabelled: In the RV144 HIV-1 vaccine efficacy trial, IgG antibody (Ab) binding levels to variable regions 1 and 2 (V1V2) of the HIV-1 envelope glycoprotein gp120 were an inverse correlate...
7.
Patel V, Jalah R, Kulkarni V, Valentin A, Rosati M, Alicea C, et al.
Proc Natl Acad Sci U S A
. 2013 Jan;
110(8):2975-80.
PMID: 23359688
We have previously shown that macaques vaccinated with DNA vectors expressing SIVmac239 antigens developed potent immune responses able to reduce viremia upon high-dose SIVmac251 challenge. To further improve vaccine-induced immunity...
8.
Bhagat R, Forteza R, Calcote C, Williams W, Bigler S, Dwyer T
Respir Care
. 2012 Mar;
57(10):1670-3.
PMID: 22417476
A patient presented with shortness of breath and pleuritic pain shortly after bilateral knee synovial injections with sodium hyaluronate (HA). He was discharged after a brief hospitalization without a diagnosis...
9.
Philibert I, Friedmann P, Williams W
JAMA
. 2002 Sep;
288(9):1112-4.
PMID: 12204081
No abstract available.